nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—POR—Mitomycin—stomach cancer	0.692	0.827	CbGbCtD
Nilutamide—POR—Doxorubicin—stomach cancer	0.0969	0.116	CbGbCtD
Nilutamide—CYP2C9—Capecitabine—stomach cancer	0.0194	0.0232	CbGbCtD
Nilutamide—CYP2C8—Fluorouracil—stomach cancer	0.0165	0.0197	CbGbCtD
Nilutamide—CYP2C9—Fluorouracil—stomach cancer	0.0115	0.0137	CbGbCtD
Nilutamide—Flutamide—AHR—stomach cancer	0.00359	0.864	CrCbGaD
Nilutamide—Enzalutamide—ALB—stomach cancer	0.000567	0.136	CrCbGaD
Nilutamide—POR—bone marrow—stomach cancer	0.000265	0.0697	CbGeAlD
Nilutamide—AR—hematopoietic system—stomach cancer	0.000244	0.0642	CbGeAlD
Nilutamide—POR—endocrine gland—stomach cancer	0.000237	0.0625	CbGeAlD
Nilutamide—CYP2C19—hematopoietic system—stomach cancer	0.000226	0.0595	CbGeAlD
Nilutamide—AR—epithelium—stomach cancer	0.000223	0.0587	CbGeAlD
Nilutamide—Decreased appetite—Fluorouracil—stomach cancer	0.000217	0.0018	CcSEcCtD
Nilutamide—Alopecia—Capecitabine—stomach cancer	0.000217	0.0018	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000215	0.00179	CcSEcCtD
Nilutamide—AR—smooth muscle tissue—stomach cancer	0.000215	0.0566	CbGeAlD
Nilutamide—Feeling abnormal—Irinotecan—stomach cancer	0.000214	0.00178	CcSEcCtD
Nilutamide—Blood creatinine increased—Doxorubicin—stomach cancer	0.000214	0.00178	CcSEcCtD
Nilutamide—POR—liver—stomach cancer	0.000214	0.0563	CbGeAlD
Nilutamide—Influenza—Epirubicin—stomach cancer	0.000213	0.00177	CcSEcCtD
Nilutamide—Back pain—Docetaxel—stomach cancer	0.000213	0.00177	CcSEcCtD
Nilutamide—Pain—Fluorouracil—stomach cancer	0.000213	0.00177	CcSEcCtD
Nilutamide—Gastrointestinal pain—Irinotecan—stomach cancer	0.000213	0.00177	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000212	0.00176	CcSEcCtD
Nilutamide—Erectile dysfunction—Methotrexate—stomach cancer	0.00021	0.00174	CcSEcCtD
Nilutamide—Dry skin—Doxorubicin—stomach cancer	0.000209	0.00174	CcSEcCtD
Nilutamide—Angina pectoris—Epirubicin—stomach cancer	0.000208	0.00173	CcSEcCtD
Nilutamide—Back pain—Capecitabine—stomach cancer	0.000206	0.00171	CcSEcCtD
Nilutamide—Body temperature increased—Irinotecan—stomach cancer	0.000206	0.00171	CcSEcCtD
Nilutamide—Abdominal pain—Irinotecan—stomach cancer	0.000206	0.00171	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000206	0.00171	CcSEcCtD
Nilutamide—Feeling abnormal—Fluorouracil—stomach cancer	0.000205	0.00171	CcSEcCtD
Nilutamide—Pneumonia—Methotrexate—stomach cancer	0.000204	0.0017	CcSEcCtD
Nilutamide—Anaemia—Docetaxel—stomach cancer	0.000204	0.00169	CcSEcCtD
Nilutamide—Depression—Methotrexate—stomach cancer	0.000203	0.00168	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000201	0.00167	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000198	0.00165	CcSEcCtD
Nilutamide—Ill-defined disorder—Capecitabine—stomach cancer	0.000198	0.00164	CcSEcCtD
Nilutamide—Syncope—Docetaxel—stomach cancer	0.000198	0.00164	CcSEcCtD
Nilutamide—Influenza—Doxorubicin—stomach cancer	0.000197	0.00164	CcSEcCtD
Nilutamide—Leukopenia—Docetaxel—stomach cancer	0.000197	0.00164	CcSEcCtD
Nilutamide—Anaemia—Capecitabine—stomach cancer	0.000197	0.00164	CcSEcCtD
Nilutamide—CYP2C8—hematopoietic system—stomach cancer	0.000197	0.0519	CbGeAlD
Nilutamide—Body temperature increased—Fluorouracil—stomach cancer	0.000197	0.00164	CcSEcCtD
Nilutamide—Sweating—Methotrexate—stomach cancer	0.000195	0.00162	CcSEcCtD
Nilutamide—Haematuria—Methotrexate—stomach cancer	0.000194	0.00161	CcSEcCtD
Nilutamide—Loss of consciousness—Docetaxel—stomach cancer	0.000194	0.00161	CcSEcCtD
Nilutamide—Weight decreased—Epirubicin—stomach cancer	0.000193	0.0016	CcSEcCtD
Nilutamide—Hyperglycaemia—Epirubicin—stomach cancer	0.000192	0.0016	CcSEcCtD
Nilutamide—Malaise—Capecitabine—stomach cancer	0.000192	0.0016	CcSEcCtD
Nilutamide—Cough—Docetaxel—stomach cancer	0.000192	0.0016	CcSEcCtD
Nilutamide—Angina pectoris—Doxorubicin—stomach cancer	0.000192	0.0016	CcSEcCtD
Nilutamide—Syncope—Capecitabine—stomach cancer	0.000191	0.00159	CcSEcCtD
Nilutamide—Pneumonia—Epirubicin—stomach cancer	0.000191	0.00159	CcSEcCtD
Nilutamide—Leukopenia—Capecitabine—stomach cancer	0.000191	0.00159	CcSEcCtD
Nilutamide—Hypertension—Docetaxel—stomach cancer	0.00019	0.00158	CcSEcCtD
Nilutamide—Chest pain—Docetaxel—stomach cancer	0.000188	0.00156	CcSEcCtD
Nilutamide—Loss of consciousness—Capecitabine—stomach cancer	0.000188	0.00156	CcSEcCtD
Nilutamide—Asthenia—Irinotecan—stomach cancer	0.000187	0.00155	CcSEcCtD
Nilutamide—Cough—Capecitabine—stomach cancer	0.000186	0.00155	CcSEcCtD
Nilutamide—Urinary tract infection—Epirubicin—stomach cancer	0.000185	0.00154	CcSEcCtD
Nilutamide—Hypertension—Capecitabine—stomach cancer	0.000184	0.00153	CcSEcCtD
Nilutamide—Dry mouth—Docetaxel—stomach cancer	0.000184	0.00152	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000183	0.00152	CcSEcCtD
Nilutamide—Sweating—Epirubicin—stomach cancer	0.000182	0.00152	CcSEcCtD
Nilutamide—Chest pain—Capecitabine—stomach cancer	0.000182	0.00151	CcSEcCtD
Nilutamide—Haematuria—Epirubicin—stomach cancer	0.000181	0.00151	CcSEcCtD
Nilutamide—Urinary tract disorder—Methotrexate—stomach cancer	0.00018	0.0015	CcSEcCtD
Nilutamide—Oedema—Docetaxel—stomach cancer	0.00018	0.00149	CcSEcCtD
Nilutamide—Discomfort—Capecitabine—stomach cancer	0.000179	0.00149	CcSEcCtD
Nilutamide—Urethral disorder—Methotrexate—stomach cancer	0.000179	0.00149	CcSEcCtD
Nilutamide—Weight decreased—Doxorubicin—stomach cancer	0.000179	0.00148	CcSEcCtD
Nilutamide—Hyperglycaemia—Doxorubicin—stomach cancer	0.000178	0.00148	CcSEcCtD
Nilutamide—Diarrhoea—Irinotecan—stomach cancer	0.000178	0.00148	CcSEcCtD
Nilutamide—Dry mouth—Capecitabine—stomach cancer	0.000178	0.00148	CcSEcCtD
Nilutamide—Pneumonia—Doxorubicin—stomach cancer	0.000177	0.00147	CcSEcCtD
Nilutamide—Shock—Docetaxel—stomach cancer	0.000177	0.00147	CcSEcCtD
Nilutamide—Pruritus—Fluorouracil—stomach cancer	0.000176	0.00146	CcSEcCtD
Nilutamide—Visual impairment—Methotrexate—stomach cancer	0.000176	0.00146	CcSEcCtD
Nilutamide—CYP2C9—hematopoietic system—stomach cancer	0.000175	0.0461	CbGeAlD
Nilutamide—Oedema—Capecitabine—stomach cancer	0.000174	0.00145	CcSEcCtD
Nilutamide—Dizziness—Irinotecan—stomach cancer	0.000172	0.00143	CcSEcCtD
Nilutamide—AR—lymphoid tissue—stomach cancer	0.000172	0.0452	CbGeAlD
Nilutamide—Anorexia—Docetaxel—stomach cancer	0.000171	0.00142	CcSEcCtD
Nilutamide—Shock—Capecitabine—stomach cancer	0.000171	0.00142	CcSEcCtD
Nilutamide—Rhinitis—Epirubicin—stomach cancer	0.000171	0.00142	CcSEcCtD
Nilutamide—Urinary tract infection—Doxorubicin—stomach cancer	0.000171	0.00142	CcSEcCtD
Nilutamide—Diarrhoea—Fluorouracil—stomach cancer	0.000171	0.00142	CcSEcCtD
Nilutamide—Hypoaesthesia—Epirubicin—stomach cancer	0.00017	0.00141	CcSEcCtD
Nilutamide—AR—digestive system—stomach cancer	0.00017	0.0447	CbGeAlD
Nilutamide—Sweating—Doxorubicin—stomach cancer	0.000169	0.0014	CcSEcCtD
Nilutamide—Urinary tract disorder—Epirubicin—stomach cancer	0.000169	0.0014	CcSEcCtD
Nilutamide—Hyperhidrosis—Capecitabine—stomach cancer	0.000168	0.0014	CcSEcCtD
Nilutamide—Oedema peripheral—Epirubicin—stomach cancer	0.000168	0.0014	CcSEcCtD
Nilutamide—Haematuria—Doxorubicin—stomach cancer	0.000168	0.00139	CcSEcCtD
Nilutamide—Urethral disorder—Epirubicin—stomach cancer	0.000167	0.00139	CcSEcCtD
Nilutamide—Anorexia—Capecitabine—stomach cancer	0.000166	0.00138	CcSEcCtD
Nilutamide—Vomiting—Irinotecan—stomach cancer	0.000165	0.00137	CcSEcCtD
Nilutamide—Dizziness—Fluorouracil—stomach cancer	0.000165	0.00137	CcSEcCtD
Nilutamide—Visual impairment—Epirubicin—stomach cancer	0.000165	0.00137	CcSEcCtD
Nilutamide—Rash—Irinotecan—stomach cancer	0.000164	0.00136	CcSEcCtD
Nilutamide—Dermatitis—Irinotecan—stomach cancer	0.000164	0.00136	CcSEcCtD
Nilutamide—POR—lymph node—stomach cancer	0.000164	0.0432	CbGeAlD
Nilutamide—Headache—Irinotecan—stomach cancer	0.000163	0.00135	CcSEcCtD
Nilutamide—Insomnia—Docetaxel—stomach cancer	0.000163	0.00135	CcSEcCtD
Nilutamide—Paraesthesia—Docetaxel—stomach cancer	0.000162	0.00134	CcSEcCtD
Nilutamide—Alopecia—Methotrexate—stomach cancer	0.000161	0.00134	CcSEcCtD
Nilutamide—Dyspnoea—Docetaxel—stomach cancer	0.00016	0.00133	CcSEcCtD
Nilutamide—Vomiting—Fluorouracil—stomach cancer	0.000158	0.00132	CcSEcCtD
Nilutamide—Rhinitis—Doxorubicin—stomach cancer	0.000158	0.00132	CcSEcCtD
Nilutamide—Dyspepsia—Docetaxel—stomach cancer	0.000158	0.00132	CcSEcCtD
Nilutamide—Insomnia—Capecitabine—stomach cancer	0.000158	0.00131	CcSEcCtD
Nilutamide—Hypoaesthesia—Doxorubicin—stomach cancer	0.000157	0.00131	CcSEcCtD
Nilutamide—Rash—Fluorouracil—stomach cancer	0.000157	0.00131	CcSEcCtD
Nilutamide—CYP2C19—digestive system—stomach cancer	0.000157	0.0414	CbGeAlD
Nilutamide—Dermatitis—Fluorouracil—stomach cancer	0.000157	0.0013	CcSEcCtD
Nilutamide—Paraesthesia—Capecitabine—stomach cancer	0.000156	0.0013	CcSEcCtD
Nilutamide—Decreased appetite—Docetaxel—stomach cancer	0.000156	0.0013	CcSEcCtD
Nilutamide—Headache—Fluorouracil—stomach cancer	0.000156	0.0013	CcSEcCtD
Nilutamide—Urinary tract disorder—Doxorubicin—stomach cancer	0.000156	0.0013	CcSEcCtD
Nilutamide—Oedema peripheral—Doxorubicin—stomach cancer	0.000156	0.00129	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000155	0.00129	CcSEcCtD
Nilutamide—Dyspnoea—Capecitabine—stomach cancer	0.000155	0.00129	CcSEcCtD
Nilutamide—Urethral disorder—Doxorubicin—stomach cancer	0.000155	0.00129	CcSEcCtD
Nilutamide—Nausea—Irinotecan—stomach cancer	0.000155	0.00128	CcSEcCtD
Nilutamide—Constipation—Docetaxel—stomach cancer	0.000154	0.00128	CcSEcCtD
Nilutamide—Pain—Docetaxel—stomach cancer	0.000154	0.00128	CcSEcCtD
Nilutamide—Back pain—Methotrexate—stomach cancer	0.000154	0.00128	CcSEcCtD
Nilutamide—Dyspepsia—Capecitabine—stomach cancer	0.000153	0.00127	CcSEcCtD
Nilutamide—Visual impairment—Doxorubicin—stomach cancer	0.000152	0.00127	CcSEcCtD
Nilutamide—Decreased appetite—Capecitabine—stomach cancer	0.000151	0.00126	CcSEcCtD
Nilutamide—Alopecia—Epirubicin—stomach cancer	0.000151	0.00125	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00015	0.00125	CcSEcCtD
Nilutamide—Constipation—Capecitabine—stomach cancer	0.000149	0.00124	CcSEcCtD
Nilutamide—Pain—Capecitabine—stomach cancer	0.000149	0.00124	CcSEcCtD
Nilutamide—Feeling abnormal—Docetaxel—stomach cancer	0.000148	0.00123	CcSEcCtD
Nilutamide—Nausea—Fluorouracil—stomach cancer	0.000148	0.00123	CcSEcCtD
Nilutamide—Ill-defined disorder—Methotrexate—stomach cancer	0.000147	0.00122	CcSEcCtD
Nilutamide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000147	0.00122	CcSEcCtD
Nilutamide—Anaemia—Methotrexate—stomach cancer	0.000147	0.00122	CcSEcCtD
Nilutamide—Tension—Epirubicin—stomach cancer	0.000146	0.00121	CcSEcCtD
Nilutamide—Nervousness—Epirubicin—stomach cancer	0.000144	0.0012	CcSEcCtD
Nilutamide—Back pain—Epirubicin—stomach cancer	0.000144	0.00119	CcSEcCtD
Nilutamide—Feeling abnormal—Capecitabine—stomach cancer	0.000144	0.00119	CcSEcCtD
Nilutamide—Malaise—Methotrexate—stomach cancer	0.000143	0.00119	CcSEcCtD
Nilutamide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000142	0.00118	CcSEcCtD
Nilutamide—Body temperature increased—Docetaxel—stomach cancer	0.000142	0.00118	CcSEcCtD
Nilutamide—Abdominal pain—Docetaxel—stomach cancer	0.000142	0.00118	CcSEcCtD
Nilutamide—Leukopenia—Methotrexate—stomach cancer	0.000142	0.00118	CcSEcCtD
Nilutamide—AR—endocrine gland—stomach cancer	0.00014	0.0369	CbGeAlD
Nilutamide—Alopecia—Doxorubicin—stomach cancer	0.00014	0.00116	CcSEcCtD
Nilutamide—Cough—Methotrexate—stomach cancer	0.000139	0.00115	CcSEcCtD
Nilutamide—Ill-defined disorder—Epirubicin—stomach cancer	0.000138	0.00115	CcSEcCtD
Nilutamide—Abdominal pain—Capecitabine—stomach cancer	0.000138	0.00114	CcSEcCtD
Nilutamide—Body temperature increased—Capecitabine—stomach cancer	0.000138	0.00114	CcSEcCtD
Nilutamide—Anaemia—Epirubicin—stomach cancer	0.000137	0.00114	CcSEcCtD
Nilutamide—Chest pain—Methotrexate—stomach cancer	0.000135	0.00112	CcSEcCtD
Nilutamide—Tension—Doxorubicin—stomach cancer	0.000135	0.00112	CcSEcCtD
Nilutamide—Malaise—Epirubicin—stomach cancer	0.000134	0.00111	CcSEcCtD
Nilutamide—Discomfort—Methotrexate—stomach cancer	0.000134	0.00111	CcSEcCtD
Nilutamide—Nervousness—Doxorubicin—stomach cancer	0.000134	0.00111	CcSEcCtD
Nilutamide—Syncope—Epirubicin—stomach cancer	0.000133	0.00111	CcSEcCtD
Nilutamide—Leukopenia—Epirubicin—stomach cancer	0.000133	0.00111	CcSEcCtD
Nilutamide—Back pain—Doxorubicin—stomach cancer	0.000133	0.00111	CcSEcCtD
Nilutamide—Loss of consciousness—Epirubicin—stomach cancer	0.000131	0.00109	CcSEcCtD
Nilutamide—CYP2C19—endocrine gland—stomach cancer	0.00013	0.0342	CbGeAlD
Nilutamide—Cough—Epirubicin—stomach cancer	0.00013	0.00108	CcSEcCtD
Nilutamide—Asthenia—Docetaxel—stomach cancer	0.000129	0.00107	CcSEcCtD
Nilutamide—Hypertension—Epirubicin—stomach cancer	0.000128	0.00107	CcSEcCtD
Nilutamide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000128	0.00106	CcSEcCtD
Nilutamide—Pruritus—Docetaxel—stomach cancer	0.000127	0.00106	CcSEcCtD
Nilutamide—Anaemia—Doxorubicin—stomach cancer	0.000127	0.00106	CcSEcCtD
Nilutamide—Chest pain—Epirubicin—stomach cancer	0.000127	0.00105	CcSEcCtD
Nilutamide—AR—liver—stomach cancer	0.000126	0.0333	CbGeAlD
Nilutamide—Hyperhidrosis—Methotrexate—stomach cancer	0.000125	0.00104	CcSEcCtD
Nilutamide—Discomfort—Epirubicin—stomach cancer	0.000125	0.00104	CcSEcCtD
Nilutamide—Asthenia—Capecitabine—stomach cancer	0.000125	0.00104	CcSEcCtD
Nilutamide—Malaise—Doxorubicin—stomach cancer	0.000124	0.00103	CcSEcCtD
Nilutamide—Dry mouth—Epirubicin—stomach cancer	0.000124	0.00103	CcSEcCtD
Nilutamide—Anorexia—Methotrexate—stomach cancer	0.000124	0.00103	CcSEcCtD
Nilutamide—Syncope—Doxorubicin—stomach cancer	0.000123	0.00102	CcSEcCtD
Nilutamide—Pruritus—Capecitabine—stomach cancer	0.000123	0.00102	CcSEcCtD
Nilutamide—Leukopenia—Doxorubicin—stomach cancer	0.000123	0.00102	CcSEcCtD
Nilutamide—Diarrhoea—Docetaxel—stomach cancer	0.000123	0.00102	CcSEcCtD
Nilutamide—CYP2C9—digestive system—stomach cancer	0.000122	0.0321	CbGeAlD
Nilutamide—Oedema—Epirubicin—stomach cancer	0.000121	0.00101	CcSEcCtD
Nilutamide—Loss of consciousness—Doxorubicin—stomach cancer	0.000121	0.001	CcSEcCtD
Nilutamide—Cough—Doxorubicin—stomach cancer	0.00012	0.000997	CcSEcCtD
Nilutamide—Shock—Epirubicin—stomach cancer	0.000119	0.000992	CcSEcCtD
Nilutamide—Diarrhoea—Capecitabine—stomach cancer	0.000119	0.00099	CcSEcCtD
Nilutamide—Dizziness—Docetaxel—stomach cancer	0.000119	0.000988	CcSEcCtD
Nilutamide—Hypertension—Doxorubicin—stomach cancer	0.000119	0.000987	CcSEcCtD
Nilutamide—Hyperhidrosis—Epirubicin—stomach cancer	0.000117	0.000974	CcSEcCtD
Nilutamide—Insomnia—Methotrexate—stomach cancer	0.000117	0.000974	CcSEcCtD
Nilutamide—Chest pain—Doxorubicin—stomach cancer	0.000117	0.000973	CcSEcCtD
Nilutamide—CYP2C19—liver—stomach cancer	0.000117	0.0308	CbGeAlD
Nilutamide—Paraesthesia—Methotrexate—stomach cancer	0.000116	0.000967	CcSEcCtD
Nilutamide—Discomfort—Doxorubicin—stomach cancer	0.000116	0.000961	CcSEcCtD
Nilutamide—Anorexia—Epirubicin—stomach cancer	0.000116	0.000961	CcSEcCtD
Nilutamide—Dyspnoea—Methotrexate—stomach cancer	0.000116	0.00096	CcSEcCtD
Nilutamide—Dizziness—Capecitabine—stomach cancer	0.000115	0.000957	CcSEcCtD
Nilutamide—Dry mouth—Doxorubicin—stomach cancer	0.000115	0.000952	CcSEcCtD
Nilutamide—Vomiting—Docetaxel—stomach cancer	0.000114	0.00095	CcSEcCtD
Nilutamide—Dyspepsia—Methotrexate—stomach cancer	0.000114	0.000948	CcSEcCtD
Nilutamide—Rash—Docetaxel—stomach cancer	0.000113	0.000942	CcSEcCtD
Nilutamide—Dermatitis—Docetaxel—stomach cancer	0.000113	0.000941	CcSEcCtD
Nilutamide—CYP2C8—endocrine gland—stomach cancer	0.000113	0.0299	CbGeAlD
Nilutamide—Decreased appetite—Methotrexate—stomach cancer	0.000113	0.000936	CcSEcCtD
Nilutamide—Headache—Docetaxel—stomach cancer	0.000113	0.000936	CcSEcCtD
Nilutamide—Oedema—Doxorubicin—stomach cancer	0.000112	0.000933	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000112	0.00093	CcSEcCtD
Nilutamide—Pain—Methotrexate—stomach cancer	0.000111	0.000921	CcSEcCtD
Nilutamide—Vomiting—Capecitabine—stomach cancer	0.000111	0.00092	CcSEcCtD
Nilutamide—Shock—Doxorubicin—stomach cancer	0.00011	0.000918	CcSEcCtD
Nilutamide—Rash—Capecitabine—stomach cancer	0.00011	0.000912	CcSEcCtD
Nilutamide—Insomnia—Epirubicin—stomach cancer	0.00011	0.000912	CcSEcCtD
Nilutamide—Dermatitis—Capecitabine—stomach cancer	0.00011	0.000911	CcSEcCtD
Nilutamide—Headache—Capecitabine—stomach cancer	0.000109	0.000906	CcSEcCtD
Nilutamide—Paraesthesia—Epirubicin—stomach cancer	0.000109	0.000905	CcSEcCtD
Nilutamide—Hyperhidrosis—Doxorubicin—stomach cancer	0.000109	0.000902	CcSEcCtD
Nilutamide—Dyspnoea—Epirubicin—stomach cancer	0.000108	0.000899	CcSEcCtD
Nilutamide—Anorexia—Doxorubicin—stomach cancer	0.000107	0.000889	CcSEcCtD
Nilutamide—Nausea—Docetaxel—stomach cancer	0.000107	0.000888	CcSEcCtD
Nilutamide—Feeling abnormal—Methotrexate—stomach cancer	0.000107	0.000888	CcSEcCtD
Nilutamide—Dyspepsia—Epirubicin—stomach cancer	0.000107	0.000887	CcSEcCtD
Nilutamide—Gastrointestinal pain—Methotrexate—stomach cancer	0.000106	0.000881	CcSEcCtD
Nilutamide—Decreased appetite—Epirubicin—stomach cancer	0.000105	0.000876	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000105	0.00087	CcSEcCtD
Nilutamide—Pain—Epirubicin—stomach cancer	0.000104	0.000862	CcSEcCtD
Nilutamide—Constipation—Epirubicin—stomach cancer	0.000104	0.000862	CcSEcCtD
Nilutamide—Nausea—Capecitabine—stomach cancer	0.000103	0.000859	CcSEcCtD
Nilutamide—Abdominal pain—Methotrexate—stomach cancer	0.000102	0.000851	CcSEcCtD
Nilutamide—Body temperature increased—Methotrexate—stomach cancer	0.000102	0.000851	CcSEcCtD
Nilutamide—CYP2C8—liver—stomach cancer	0.000102	0.0269	CbGeAlD
Nilutamide—Insomnia—Doxorubicin—stomach cancer	0.000102	0.000844	CcSEcCtD
Nilutamide—Paraesthesia—Doxorubicin—stomach cancer	0.000101	0.000838	CcSEcCtD
Nilutamide—CYP2C9—endocrine gland—stomach cancer	0.000101	0.0265	CbGeAlD
Nilutamide—Dyspnoea—Doxorubicin—stomach cancer	0.0001	0.000832	CcSEcCtD
Nilutamide—Feeling abnormal—Epirubicin—stomach cancer	0.0001	0.000831	CcSEcCtD
Nilutamide—Gastrointestinal pain—Epirubicin—stomach cancer	9.92e-05	0.000824	CcSEcCtD
Nilutamide—Dyspepsia—Doxorubicin—stomach cancer	9.88e-05	0.000821	CcSEcCtD
Nilutamide—Decreased appetite—Doxorubicin—stomach cancer	9.76e-05	0.000811	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.69e-05	0.000805	CcSEcCtD
Nilutamide—AR—lymph node—stomach cancer	9.68e-05	0.0255	CbGeAlD
Nilutamide—Pain—Doxorubicin—stomach cancer	9.6e-05	0.000798	CcSEcCtD
Nilutamide—Constipation—Doxorubicin—stomach cancer	9.6e-05	0.000798	CcSEcCtD
Nilutamide—Abdominal pain—Epirubicin—stomach cancer	9.59e-05	0.000797	CcSEcCtD
Nilutamide—Body temperature increased—Epirubicin—stomach cancer	9.59e-05	0.000797	CcSEcCtD
Nilutamide—Asthenia—Methotrexate—stomach cancer	9.3e-05	0.000773	CcSEcCtD
Nilutamide—Feeling abnormal—Doxorubicin—stomach cancer	9.25e-05	0.000769	CcSEcCtD
Nilutamide—Gastrointestinal pain—Doxorubicin—stomach cancer	9.18e-05	0.000763	CcSEcCtD
Nilutamide—Pruritus—Methotrexate—stomach cancer	9.17e-05	0.000762	CcSEcCtD
Nilutamide—CYP2C9—liver—stomach cancer	9.07e-05	0.0239	CbGeAlD
Nilutamide—Abdominal pain—Doxorubicin—stomach cancer	8.87e-05	0.000737	CcSEcCtD
Nilutamide—Body temperature increased—Doxorubicin—stomach cancer	8.87e-05	0.000737	CcSEcCtD
Nilutamide—Diarrhoea—Methotrexate—stomach cancer	8.87e-05	0.000737	CcSEcCtD
Nilutamide—Asthenia—Epirubicin—stomach cancer	8.7e-05	0.000723	CcSEcCtD
Nilutamide—Pruritus—Epirubicin—stomach cancer	8.58e-05	0.000713	CcSEcCtD
Nilutamide—Dizziness—Methotrexate—stomach cancer	8.57e-05	0.000712	CcSEcCtD
Nilutamide—Diarrhoea—Epirubicin—stomach cancer	8.3e-05	0.00069	CcSEcCtD
Nilutamide—Vomiting—Methotrexate—stomach cancer	8.24e-05	0.000685	CcSEcCtD
Nilutamide—Rash—Methotrexate—stomach cancer	8.17e-05	0.000679	CcSEcCtD
Nilutamide—Dermatitis—Methotrexate—stomach cancer	8.17e-05	0.000679	CcSEcCtD
Nilutamide—Headache—Methotrexate—stomach cancer	8.12e-05	0.000675	CcSEcCtD
Nilutamide—Asthenia—Doxorubicin—stomach cancer	8.05e-05	0.000669	CcSEcCtD
Nilutamide—Dizziness—Epirubicin—stomach cancer	8.02e-05	0.000667	CcSEcCtD
Nilutamide—Pruritus—Doxorubicin—stomach cancer	7.94e-05	0.00066	CcSEcCtD
Nilutamide—Vomiting—Epirubicin—stomach cancer	7.71e-05	0.000641	CcSEcCtD
Nilutamide—Nausea—Methotrexate—stomach cancer	7.7e-05	0.00064	CcSEcCtD
Nilutamide—Diarrhoea—Doxorubicin—stomach cancer	7.68e-05	0.000638	CcSEcCtD
Nilutamide—Rash—Epirubicin—stomach cancer	7.65e-05	0.000636	CcSEcCtD
Nilutamide—Dermatitis—Epirubicin—stomach cancer	7.64e-05	0.000635	CcSEcCtD
Nilutamide—Headache—Epirubicin—stomach cancer	7.6e-05	0.000631	CcSEcCtD
Nilutamide—Dizziness—Doxorubicin—stomach cancer	7.42e-05	0.000617	CcSEcCtD
Nilutamide—Nausea—Epirubicin—stomach cancer	7.21e-05	0.000599	CcSEcCtD
Nilutamide—Vomiting—Doxorubicin—stomach cancer	7.14e-05	0.000593	CcSEcCtD
Nilutamide—Rash—Doxorubicin—stomach cancer	7.08e-05	0.000588	CcSEcCtD
Nilutamide—Dermatitis—Doxorubicin—stomach cancer	7.07e-05	0.000588	CcSEcCtD
Nilutamide—Headache—Doxorubicin—stomach cancer	7.03e-05	0.000584	CcSEcCtD
Nilutamide—Nausea—Doxorubicin—stomach cancer	6.67e-05	0.000554	CcSEcCtD
Nilutamide—AR—Integrated Breast Cancer Pathway—JUN—stomach cancer	4.67e-05	0.00131	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RXRB—stomach cancer	4.67e-05	0.00131	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPL13—stomach cancer	4.58e-05	0.00128	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPL18—stomach cancer	4.58e-05	0.00128	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—JUN—stomach cancer	4.55e-05	0.00128	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	4.4e-05	0.00123	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	4.39e-05	0.00123	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	4.29e-05	0.0012	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	4.27e-05	0.0012	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPS15—stomach cancer	4.27e-05	0.0012	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPS21—stomach cancer	4.27e-05	0.0012	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTP1—stomach cancer	4.22e-05	0.00118	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SNRPB—stomach cancer	4.2e-05	0.00118	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—GSTP1—stomach cancer	4.16e-05	0.00117	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—stomach cancer	4.08e-05	0.00114	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	4.07e-05	0.00114	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—stomach cancer	3.98e-05	0.00112	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	3.92e-05	0.0011	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—SMAD4—stomach cancer	3.9e-05	0.00109	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.88e-05	0.00109	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTM1—stomach cancer	3.87e-05	0.00109	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.87e-05	0.00109	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—GSTM1—stomach cancer	3.82e-05	0.00107	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RORA—stomach cancer	3.77e-05	0.00106	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTP1—stomach cancer	3.76e-05	0.00106	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MYC—stomach cancer	3.76e-05	0.00105	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.75e-05	0.00105	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—GSTP1—stomach cancer	3.71e-05	0.00104	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MAPK1—stomach cancer	3.67e-05	0.00103	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—EGFR—stomach cancer	3.67e-05	0.00103	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.66e-05	0.00103	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ACAD8—stomach cancer	3.62e-05	0.00102	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	3.58e-05	0.001	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	3.54e-05	0.000994	CbGpPWpGaD
Nilutamide—AR—Gene Expression—DNMT3B—stomach cancer	3.54e-05	0.000992	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—KRAS—stomach cancer	3.47e-05	0.000973	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPL15—stomach cancer	3.47e-05	0.000972	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTM1—stomach cancer	3.46e-05	0.00097	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTP1—stomach cancer	3.43e-05	0.000962	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—GSTM1—stomach cancer	3.41e-05	0.000957	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—stomach cancer	3.41e-05	0.000956	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTP1—stomach cancer	3.38e-05	0.000949	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	3.38e-05	0.000948	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RARB—stomach cancer	3.37e-05	0.000946	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	3.33e-05	0.000934	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ACAD8—stomach cancer	3.24e-05	0.000907	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPS26—stomach cancer	3.23e-05	0.000907	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GMPR2—stomach cancer	3.23e-05	0.000906	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	3.2e-05	0.000897	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	3.16e-05	0.000887	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTM1—stomach cancer	3.15e-05	0.000884	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	3.12e-05	0.000875	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	3.11e-05	0.000873	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	3.11e-05	0.000872	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—stomach cancer	3.08e-05	0.000865	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—RORA—stomach cancer	3.08e-05	0.000864	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	3.04e-05	0.000854	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	3.04e-05	0.000854	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	2.97e-05	0.000834	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SUCLG1—stomach cancer	2.95e-05	0.000829	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—IDH3B—stomach cancer	2.95e-05	0.000829	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ACAD8—stomach cancer	2.95e-05	0.000827	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.9e-05	0.000813	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GMPR2—stomach cancer	2.88e-05	0.000809	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	2.88e-05	0.000809	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.88e-05	0.000806	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPB1—stomach cancer	2.83e-05	0.000793	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	2.78e-05	0.000781	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—RORA—stomach cancer	2.75e-05	0.000771	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—stomach cancer	2.75e-05	0.000771	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPS19—stomach cancer	2.75e-05	0.000771	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NDUFS1—stomach cancer	2.75e-05	0.00077	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NDUFV1—stomach cancer	2.75e-05	0.00077	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—PPARG—stomach cancer	2.71e-05	0.00076	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	2.71e-05	0.00076	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	2.68e-05	0.000753	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.64e-05	0.000741	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—IDH3B—stomach cancer	2.64e-05	0.00074	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SUCLG1—stomach cancer	2.64e-05	0.00074	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GMPR2—stomach cancer	2.63e-05	0.000737	CbGpPWpGaD
Nilutamide—AR—Gene Expression—DNMT1—stomach cancer	2.63e-05	0.000737	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPA8—stomach cancer	2.59e-05	0.000727	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.56e-05	0.000717	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	2.54e-05	0.000712	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	2.51e-05	0.000703	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NDUFS1—stomach cancer	2.45e-05	0.000688	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NDUFV1—stomach cancer	2.45e-05	0.000688	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PGLS—stomach cancer	2.45e-05	0.000687	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—BLVRB—stomach cancer	2.45e-05	0.000687	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—SERPINE1—stomach cancer	2.44e-05	0.000685	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPS6—stomach cancer	2.43e-05	0.000682	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—IDH3B—stomach cancer	2.4e-05	0.000674	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SUCLG1—stomach cancer	2.4e-05	0.000674	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	2.4e-05	0.000672	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPAP2A—stomach cancer	2.34e-05	0.000655	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.25e-05	0.00063	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NDUFV1—stomach cancer	2.24e-05	0.000627	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NDUFS1—stomach cancer	2.24e-05	0.000627	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PGLS—stomach cancer	2.19e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—BLVRB—stomach cancer	2.19e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	2.19e-05	0.000613	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPAP2A—stomach cancer	2.08e-05	0.000585	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA1—stomach cancer	2.08e-05	0.000584	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CKB—stomach cancer	2.08e-05	0.000584	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—FBP1—stomach cancer	2.08e-05	0.000584	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NDUFA2—stomach cancer	2.08e-05	0.000584	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPP2R1A—stomach cancer	2.02e-05	0.000567	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2e-05	0.000562	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PGLS—stomach cancer	1.99e-05	0.000559	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—BLVRB—stomach cancer	1.99e-05	0.000559	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLIN2—stomach cancer	1.96e-05	0.000549	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA2—stomach cancer	1.9e-05	0.000534	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPAP2A—stomach cancer	1.9e-05	0.000533	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SMAD4—stomach cancer	1.88e-05	0.000526	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NDUFA2—stomach cancer	1.86e-05	0.000521	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CKB—stomach cancer	1.86e-05	0.000521	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FBP1—stomach cancer	1.86e-05	0.000521	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA1—stomach cancer	1.86e-05	0.000521	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NT5E—stomach cancer	1.86e-05	0.00052	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PGAM1—stomach cancer	1.86e-05	0.00052	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	1.83e-05	0.000513	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDH7A1—stomach cancer	1.77e-05	0.000496	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLCE1—stomach cancer	1.77e-05	0.000496	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLIN2—stomach cancer	1.75e-05	0.00049	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ERCC2—stomach cancer	1.71e-05	0.00048	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA2—stomach cancer	1.7e-05	0.000477	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—UMPS—stomach cancer	1.7e-05	0.000476	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CKB—stomach cancer	1.69e-05	0.000475	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NDUFA2—stomach cancer	1.69e-05	0.000475	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA1—stomach cancer	1.69e-05	0.000475	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FBP1—stomach cancer	1.69e-05	0.000475	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PGAM1—stomach cancer	1.66e-05	0.000464	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NT5E—stomach cancer	1.66e-05	0.000464	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLIN2—stomach cancer	1.59e-05	0.000447	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLCE1—stomach cancer	1.58e-05	0.000443	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDH7A1—stomach cancer	1.58e-05	0.000443	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PDHA1—stomach cancer	1.58e-05	0.000442	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ECHS1—stomach cancer	1.58e-05	0.000442	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA2—stomach cancer	1.55e-05	0.000435	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MYC—stomach cancer	1.55e-05	0.000433	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—UMPS—stomach cancer	1.51e-05	0.000425	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NT5E—stomach cancer	1.51e-05	0.000424	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PGAM1—stomach cancer	1.51e-05	0.000424	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TYMP—stomach cancer	1.48e-05	0.000416	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—FADS1—stomach cancer	1.48e-05	0.000416	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.44e-05	0.000404	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLCE1—stomach cancer	1.44e-05	0.000404	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PDHA1—stomach cancer	1.41e-05	0.000395	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ECHS1—stomach cancer	1.41e-05	0.000395	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SREBF2—stomach cancer	1.39e-05	0.00039	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—UMPS—stomach cancer	1.38e-05	0.000387	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—RORA—stomach cancer	1.37e-05	0.000385	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TYMP—stomach cancer	1.32e-05	0.000371	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FADS1—stomach cancer	1.32e-05	0.000371	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PPARG—stomach cancer	1.31e-05	0.000366	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDOB—stomach cancer	1.29e-05	0.000361	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PDHA1—stomach cancer	1.28e-05	0.00036	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ECHS1—stomach cancer	1.28e-05	0.00036	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SREBF2—stomach cancer	1.24e-05	0.000348	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—RORA—stomach cancer	1.23e-05	0.000344	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.21e-05	0.00034	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.21e-05	0.000339	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FADS1—stomach cancer	1.21e-05	0.000339	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TYMP—stomach cancer	1.21e-05	0.000339	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALOX5—stomach cancer	1.2e-05	0.000335	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—DPYD—stomach cancer	1.18e-05	0.00033	CbGpPWpGaD
Nilutamide—AR—Gene Expression—SERPINE1—stomach cancer	1.18e-05	0.00033	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDOB—stomach cancer	1.15e-05	0.000322	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SREBF2—stomach cancer	1.13e-05	0.000317	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—RORA—stomach cancer	1.12e-05	0.000313	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.08e-05	0.000304	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.08e-05	0.000303	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALOX5—stomach cancer	1.07e-05	0.000299	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.07e-05	0.000299	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—DPYD—stomach cancer	1.05e-05	0.000294	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDOB—stomach cancer	1.05e-05	0.000294	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTT1—stomach cancer	1.04e-05	0.000292	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2A6—stomach cancer	1.03e-05	0.000288	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKR1C3—stomach cancer	1e-05	0.000281	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	9.87e-06	0.000277	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.85e-06	0.000276	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ENO1—stomach cancer	9.75e-06	0.000273	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALOX5—stomach cancer	9.73e-06	0.000273	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.59e-06	0.000269	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—DPYD—stomach cancer	9.57e-06	0.000268	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.52e-06	0.000267	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTT1—stomach cancer	9.28e-06	0.00026	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2A6—stomach cancer	9.18e-06	0.000257	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKR1C3—stomach cancer	8.93e-06	0.00025	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ENO1—stomach cancer	8.7e-06	0.000244	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.68e-06	0.000243	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CD44—stomach cancer	8.64e-06	0.000242	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.56e-06	0.00024	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTT1—stomach cancer	8.47e-06	0.000237	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.39e-06	0.000235	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2A6—stomach cancer	8.37e-06	0.000235	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKR1C3—stomach cancer	8.14e-06	0.000228	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ENO1—stomach cancer	7.93e-06	0.000222	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.8e-06	0.000219	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CD44—stomach cancer	7.72e-06	0.000216	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAPK3—stomach cancer	7.65e-06	0.000215	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.49e-06	0.00021	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MYC—stomach cancer	7.44e-06	0.000209	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPP2R1A—stomach cancer	7.35e-06	0.000206	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTP1—stomach cancer	7.21e-06	0.000202	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HMOX1—stomach cancer	7.11e-06	0.000199	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CD44—stomach cancer	7.04e-06	0.000197	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.83e-06	0.000191	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TYMS—stomach cancer	6.7e-06	0.000188	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—stomach cancer	6.63e-06	0.000186	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPP2R1A—stomach cancer	6.56e-06	0.000184	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTP1—stomach cancer	6.44e-06	0.00018	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HMOX1—stomach cancer	6.35e-06	0.000178	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ERCC2—stomach cancer	6.23e-06	0.000175	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TYMS—stomach cancer	5.98e-06	0.000168	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPP2R1A—stomach cancer	5.98e-06	0.000168	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—stomach cancer	5.91e-06	0.000166	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTP1—stomach cancer	5.87e-06	0.000165	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTHFR—stomach cancer	5.86e-06	0.000164	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HMOX1—stomach cancer	5.79e-06	0.000162	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ERCC2—stomach cancer	5.56e-06	0.000156	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TYMS—stomach cancer	5.46e-06	0.000153	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAV1—stomach cancer	5.4e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—stomach cancer	5.39e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA1—stomach cancer	5.39e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTHFR—stomach cancer	5.23e-06	0.000147	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.16e-06	0.000145	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ERCC2—stomach cancer	5.07e-06	0.000142	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAV1—stomach cancer	4.82e-06	0.000135	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA1—stomach cancer	4.81e-06	0.000135	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTHFR—stomach cancer	4.77e-06	0.000134	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPARG—stomach cancer	4.75e-06	0.000133	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.61e-06	0.000129	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAV1—stomach cancer	4.4e-06	0.000123	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA1—stomach cancer	4.39e-06	0.000123	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—stomach cancer	4.27e-06	0.00012	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPARG—stomach cancer	4.24e-06	0.000119	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.2e-06	0.000118	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NOS3—stomach cancer	4.08e-06	0.000115	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPARG—stomach cancer	3.86e-06	0.000108	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—stomach cancer	3.81e-06	0.000107	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—stomach cancer	3.74e-06	0.000105	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NOS3—stomach cancer	3.65e-06	0.000102	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—stomach cancer	3.47e-06	9.75e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—stomach cancer	3.33e-06	9.35e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NOS3—stomach cancer	3.32e-06	9.32e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—stomach cancer	3.04e-06	8.53e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CA—stomach cancer	2.3e-06	6.45e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CA—stomach cancer	2.05e-06	5.75e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.87e-06	5.25e-05	CbGpPWpGaD
